Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer – an interim analysis (Prostate Cancer and Prostatic Diseases, (2023), 26, 3, (596-601), 10.1038/s41391-023-00675-1)

Abstract

Correction to: Prostate Cancer and Prostatic Diseaseshttps://doi.org/10.1038/s41391-023-00675-1, published online 16 May 2023 The final sentence in the Results section of the abstract should read: At 2.5 years, patients with low-risk EPI scores from both arms had less HGPC than high-risk EPI score patients (7.9% vs 27.3%, p < 0.001) and the EPI arm found 21.8% more HGPC than the SOC arm. Instead, the final sentence in the Results section of the abstract currently reads: At 2.5 years, patients with low-risk EPI scores from both arms had less HGPC than high-risk EPI score patients (7.9% vs 26.8%, p < 0.001) and the EPI arm found 18% more HGPC than the SOC arm. The original article has been corrected.